XY
Lv511
810 积分
2023-10-14 加入
-
Clinical Update on an Anti-Alzheimer Drug Candidate CT1812: A Sigma-2 Receptor Antagonist
9天前
已完结
-
Mechanisms and treatment of pulmonary arterial hypertension
29天前
已完结
-
The enduring metabolic improvement of combining dual amylin and calcitonin receptor agonist and semaglutide treatments in a rat model of obesity and diabetes
1个月前
已完结
-
102 BB-031 Recanalizes MCAO and Reduces Inflammation in Canine Model of LVO Stroke
2个月前
已完结
-
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
2个月前
已完结
-
Soluble low affinity nerve growth factor receptor (sLNGFR) may regulate pain in knee osteoarthritis
2个月前
已完结
-
Safety, tolerability, and pharmacokinetics of AZD5462, a small molecule agonist of the RXFP1 relaxin receptor
2个月前
已完结
-
Design, synthesis and biological evaluation of novel cyano-cinnamate derivatives as mitochondrial pyruvate carrier inhibitors
2个月前
已完结
-
Uncoupler therapy for NAFLD: is flushing a possible harbinger of a safety concern? – Authors' reply
3个月前
已完结
-
Safety and efficacy of once-daily HU6 versus placebo in people with non-alcoholic fatty liver disease and high BMI: a randomised, double-blind, placebo-controlled, phase 2a trial
3个月前
已完结